Chinese Sle Treatment And Research Group

Researchers are testing whether ivarmacitinib, an oral drug, works as well as prednisone for controlling arthritis and rash in adults with mild-to-moderate lupus. About 294 participants receive either ivarmacitinib or prednisone for 24 weeks. The goal is to see if ivarmacitinib c…

This 52-week study will compare three drugs—tocilizumab, telitacicept, and methotrexate—in 204 people with rheumatoid arthritis who also have interstitial lung disease. The main goal is to see which drug best improves lung function. Participants will continue their usual arthriti…

This study tests two new drugs, vunakizumab and ivarmacitinib, for people with active Takayasu arteritis (TAK), a rare disease that causes inflammation in large blood vessels. The trial will enroll 180 adults aged 18-70 whose disease is still active despite standard treatments. R…